UK court rules against NICE over Alzheimer's guidance
The UK's Court of Appeal has ruled that the National Institute for Health and Clinical Excellence has failed to act fairly in preparing its current Alzheimer's guidance, which in effect prohibits the use of anti-dementia medicines for patients with mild Alzheimer's disease, reported the PharmaTimes.
9 May 2008 2:40pm
LATEST NEWS HEADLINES
Inverness Medical acquires Matria Healthcare
Inverness Medical Innovations has completed the acquisition of Matria Healthcare, a provider of comprehensive, integrated health management services particularly in the areas of women's and children's health, cardiology and oncology.9 May 2008 2:13pm
Invitrogen and WARF sign licensing agreement
Invitrogen and the Wisconsin Alumni Research Foundation have signed a license for human embryonic stem cell patents for the development of research tools.9 May 2008 2:09pm
Ziopharm granted orphan designation for palifosfamide
Ziopharm Oncology has announced that the FDA has granted orphan drug designation to palifosfamide in the treatment of soft tissue sarcoma.9 May 2008 2:06pm
Eusa Pharma acquires Cytogen
Eusa Pharma has completed its acquisition of Cytogen, following the approval of Cytogen's shareholders.9 May 2008 2:04pm
Cytopia and Cancer Therapeutics join hands in drug discovery
Cytopia has entered into an anticancer drug discovery and development collaboration with Cancer Therapeutics CRC Pty.9 May 2008 1:12pm
OTHER RECENT NEWS